You Searched For "mrna stock price" and got 20 results
Sort By:
1 min read
Moderna soars 6% as it begins vaccine testing in babies and children
Moderna and Johnson & Johnson's vaccines are approved for adults over 18, while the vaccine from Pf…
Isabelle Lee
2 mins read
Arcturus Therapeutics plummets 53% after analyst downgrades following COVID-19 vaccine trial updates
The Singapore Health Sciences Authority approved the Arcturus vaccine candidate for Phase 2 clinica…
Emily Graffeo
1 min read
These were the 10 best-performing stocks in the S&P 500 in 2021
The benchmark stock index has returned about 30% in 2021, helped by stellar corporate earnings and …
Isabelle Lee
2 mins read
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021
The biotech firm initially fell in premarket trading as investors focused on a second delay to its …
Ben Winck
2 mins read
Biotech stocks have hammered hedge funds this year. Here are 5 funds with soured bets on the sector.
The SPDR S&P Biotech ETF is down more than 22% year-to-date, moving almost exactly opposite the S&P…
Matthew Fox
2 mins read
Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine
Pfizer is one of several firms racing to introduce the first effective coronavirus vaccine, with Mo…
Ben Winck
1 min read
Bill Gates-backed CureVac jumps 18% on report it's in advanced talks with the EU for 225 million doses of its potential COVID-19 vaccine
The contract would also give the European Commission the option to purchase an additional 180 milli…
Carmen Reinicke
2 mins read
Moderna surges 10% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine
Moderna separately said the deal is worth $1.53 billion, and the government can purchase up to 400 …
Carmen Reinicke
2 mins read
Moderna skyrockets 11% after receiving additional $472 million of funding, starting phase-3 trial of COVID-19 vaccine
Moderna's total award from the Biomedical Advanced Research and Development Authority is roughly $9…
Carmen Reinicke
1 min read
Moderna will surge another 60% on the value of its potential coronavirus vaccine, according to one Wall Street firm
Piper Sandler also estimated that a coronavirus vaccine could generate more than $18 billion in rev…
Carmen Reinicke
1 min read
US stocks gain as jump in retail sales in June points to steady pace of economic recovery
US stocks gained on Friday after a day of market declines as investor concerns about rising inflati…
Matthew Fox
2 mins read
Dow slides 300 points to cap off first weekly decline in a month amid inflation worries
If inflation doesn't cool off soon, the Fed could be forced to change course sooner than it has bee…
Matthew Fox
2 mins read
The billionaire scientist who developed Pfizer's breakthrough vaccine has not sold any shares in partner BioNTech's surging stock
Sahin and his wife, Ozlem Tureci, are the "dream team" couple whose company partnered with Pfizer t…
Shalini Nagarajan
2 mins read
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox
3 mins read
Global stocks rise on further dose of COVID-19 vaccine positivity and strong China factory data
Investors are eagerly anticipating results from vaccine candidates including Moderna, AstraZeneca, …
Shalini Nagarajan
2 mins read
Moderna was the most-bought stock for retail traders in the week leading up to its 16% single-day plunge
Wall Street analysts appear less keen than retail traders on vaccine makers such as Moderna, after …
Harry Robertson
2 mins read
10 things before the opening bell
Moderna spikes, US Binance head is out, Tesla may surge.
Phil Rosen
3 mins read
Moderna's betting big on personalized vaccines to treat cancer. Its CEO lays out his vision for how it could transform healthcare.
Plotting the next act beyond COVID-19, Moderna CEO Stephane Bancel told Insider his vision for mRNA…
Andrew Dunn
2 mins read
Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease
"Now we are an oncology company," Moderna CEO Stéphane Bancel told Insider.
Andrew Dunn
3 mins read
Experts allay fears: It is Covid that triggers heart attacks, not vaccines
There has been a rising spate of heart attacks in India, particularly post Covid-19 pandemic. While…